JOSEPH TRAN: Open Payments
NPI 1649916354 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$157 in 7 payments from 6 companies in 2025. Trend: 2023 $301 · 2024 $433 · 2025 $157
Food & beverage: $157
| Company | Payments | Amount |
|---|---|---|
| Cochlear Americas | 1 | $56 |
| ABBVIE INC. | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Amgen Inc. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE, LEQVIO, EVENITY, ELIQUIS, VRAYLAR, FARXIGA, TEFLARO.
Industry payments across KS — which companies pay providers there.
